In fact, there appear to be distinct roles for p300 in mouse models of myeloid malignancies: an oncogenic role in AML1-ETO-driven AML33 and a tumor suppressor role in MDS driven by the NUP98-HOXD13 (NHD13) fusion protein36. Here, HOXD13 is linked to myelodysplastic syndrome.